High Tech Pharm Co Ltd
KOSDAQ:106190
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
High Tech Pharm Co Ltd
Inventory
High Tech Pharm Co Ltd
Inventory Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
H
|
High Tech Pharm Co Ltd
KOSDAQ:106190
|
Inventory
₩43.7B
|
CAGR 3-Years
44%
|
CAGR 5-Years
19%
|
CAGR 10-Years
16%
|
|
|
Yuhan Corp
KRX:000100
|
Inventory
₩372.8B
|
CAGR 3-Years
11%
|
CAGR 5-Years
8%
|
CAGR 10-Years
4%
|
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Inventory
₩100.2B
|
CAGR 3-Years
3%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Inventory
₩338.8B
|
CAGR 3-Years
8%
|
CAGR 5-Years
2%
|
CAGR 10-Years
8%
|
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Inventory
₩47.8B
|
CAGR 3-Years
15%
|
CAGR 5-Years
14%
|
CAGR 10-Years
10%
|
|
|
C
|
Caregen Co Ltd
KOSDAQ:214370
|
Inventory
₩22.7B
|
CAGR 3-Years
41%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
High Tech Pharm Co Ltd
Glance View
HIGH TECH PHARM Co., Ltd. engages in the manufacture and sale of raw materials for injectable antibiotic products. The company is headquartered in Chungju, Chungcheongbuk-Do and currently employs 99 full-time employees. The company went IPO on 2010-07-28. CO., LTD. is a Korea-based company mainly engaged in the manufacture of antibiotic pharmaceutical ingredients for injections. The firm's products include sterile imipenem, sterile cilastatin sodium, sterile blended imipenem and cilastatin sodium, injectable sterile meropenem, injectable sterile panipenem, faropenem and others. The firm distributes its products within domestic market and to overseas markets.
See Also
What is High Tech Pharm Co Ltd's Inventory?
Inventory
43.7B
KRW
Based on the financial report for Dec 31, 2025, High Tech Pharm Co Ltd's Inventory amounts to 43.7B KRW.
What is High Tech Pharm Co Ltd's Inventory growth rate?
Inventory CAGR 10Y
16%
Over the last year, the Inventory growth was 26%. The average annual Inventory growth rates for High Tech Pharm Co Ltd have been 44% over the past three years , 19% over the past five years , and 16% over the past ten years .
